Arkolith/Insider Trading/ORKA/Form 4

Agarwal Arjun

Senior Vice President, FinanceOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$846K
Net Open-Market Flow
-$846K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)9K$12.50$107K24K
Jul 13, 2026Option exercise(M)1K$34.39$50K25K
Jul 13, 2026Sell(S)300$83.07$25K25K
Jul 13, 2026Sell(S)4K$84.26$315K21K
Jul 13, 2026Sell(S)6K$84.90$480K16K
Jul 13, 2026Sell(S)300$85.63$26K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)9K—$0101K
Jul 13, 2026Option exercise(M)1K—$061K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML